Identification and optimization of the chemical, series of chemicals or bio-molecule that will interact with the target using impartial, expert opinion about the best equipment, services and the latest techniques
High recovery sample preparation for drug analysis and screening: LiChrolut® TSC is a selective and efficient solid phase extraction sorbent designed for clean-up of pharmaceutical products and drugs obtained from blood, plasma and urine. LiChrolut® TSC belongs to the family of the so-called “mixed-mode phases”. The combination of a reversed-phase and a cation exchange mechanism gives rise to retention of the analyte on the st…
For reproducible sample preparation: LiChrolut® CN and NH2 are medium polar phases for solid phase extraction, which produces excellent reproducibility of sample preparation. This results a combination of high chemical stability and guaranteed capacity. LiChrolut® CN and NH2 are suitable for both polar and non-polar extractions. These medium polar phases have, in addition to a short-chained propyl-spacer, a polar functional gr…
Human Cav2.2/β3/α2δ calcium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6159. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , QPatch HT™ , FLIPR®
Human Nav1.8/b3 sodium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6011. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , QPatch HT™ , IonWorks Quattro®
Human a3/β4 Nicotinic Acetylcholine Receptor-expressing, stable replicating cell line (CHO-K1). Cat#: CT6021. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: QPatch HT™
Human GABAA (α5β2γ2) Receptor-expressing, stable replicating cell line (CHO-K1). Cat#: CT6119. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: FLIPR®
Human GABAA (a5β2γ2) Receptor-expressing, stable replicating cell line (CHO-K1). Cat#: CT6119. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: FLIPR®
Human Cav2.2/b3/a2d calcium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6159. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , QPatch HT™ , FLIPR®
Human Cav2.1/b4/a2d calcium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6196. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , QPatch HT™
Human GABAA (α3/β2/γ2) Receptor-expressing, transiently transfected cells (HEK293). Cat#: CT7022. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, FLIPR®
Human a7 Nicotinic Acetylcholine Receptor-expressing, stable replicating cell line (CHO-K1). Cat#: CT6201. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: QPatch HT™ , FLIPR®
Human Cav2.1/β4/α2δ calcium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6196. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , QPatch HT™
Human Nav1.8/β3 ion channel-expressing, division-arrested cells (CHO-K1). Cat#: CT4011. Three vials of Cyropreserved irradiated cells, 2x10E6 cells/vial (6x10E6 cells total). Platform validation: PatchXpress®
Human α3/β4 Nicotinic Receptor-expressing, division-arrested cells (CHO-K1). Cat#: CT4021. Cryopreserved irradiated cells, 6 million cells per vial.. Platform validation: FlexStation III
Highest capacity for solid phase extraction: LiChrolut® EN saves time and money in solid-phase extraction as less time is required for conditioning and drying. In addition, only a little solvent is required for elution of the analytes from the cartridge bed. The reduced quantity of solvent leads to a lower degree of contamination and to an increase in detection sensitivity. This improves the analysis of the relevant extracted…
Human GABAA (α5/β2/γ2) ion channel-expressing, division-arrested cells (CHO-K1). Cat#: CT4119. Cryopreserved irradiated cells, 6 million cells per vial.. Platform validation: FlexStation III
Human GABAA (a5/b2/g2) ion channel-expressing, division-arrested cells (CHO-K1). Cat#: CT4119. Cryopreserved irradiated cells, 6 million cells per vial.. Platform validation: FlexStation III
Human Cav2.2/b3/a2d1 ion channel-expressing, division-arrested cells (CHO-K1). Cat#: CT4159. Three vials of Cyropreserved irradiated cells, 2x10E6 cells/vial (6x10E6 cells total). Platform validation: PatchXpress®
Human GABAA (α2β2γ2) Receptor-expressing, stable replicating cell line (CHO-K1). Cat#: CT6118. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: FLIPR®
Human α7+RIC-3 Nicotinic Receptor-expressing, division-arrested cells (CHO-K1). Cat#: CT4201. Cryopreserved irradiated cells, 6 million cells per vial.. Platform validation: FlexStation III
Human GABAA (a3/b2/g2) Receptor-expressing, transiently transfected cells (HEK293). Cat#: CT7022. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, FLIPR®
Human b2 Adrenergic Receptor-expressing GPCR (G protein-coupled receptor) stable, replicating cell line (CHO-K1). Cat#: A600. Cryopreserved cells, 6 million cells per vial
Human b2 Adrenergic Receptor-expressing GPCR (G protein-coupled receptor) division-arrested cells (CHO-K1). Cat#: A400. Cryopreserved irradiated cells, 6 million cells per vial
Human a3/β4 Nicotinic Receptor membrane preparation derived from stable, replicating cell line. (Cat#: CT3021)
Human NCX1 Na+/Ca2+ Exhanger-expressing, stable replicating cell line (HEK293). Cat#: CT6206. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: FLIPR®
